Provided by Tiger Trade Technology Pte. Ltd.

PMV Pharmaceuticals

1.48
-0.0250-1.67%
Volume:299.71K
Turnover:446.36K
Market Cap:111.38M
PE:-1.04
High:1.54
Open:1.51
Low:1.46
Close:1.50
52wk High:1.91
52wk Low:1.02
Shares:75.51M
Float Shares:61.14M
Volume Ratio:0.28
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4131
EPS(LYR):-1.4800
ROE:-70.93%
ROA:-42.39%
PB:1.56
PE(LYR):-1.00

Loading ...

PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial

TIPRANKS
·
Sep 01

PMV Pharmaceuticals announces common stock, warrants offering

TIPRANKS
·
Sep 01

PMV Pharma Launches Underwritten Public Offering of Common Stock, Warrants

Reuters
·
Sep 01

PMV Pharma Announces Proposed Public Offering of Securities

THOMSON REUTERS
·
Sep 01

PMV Pharma Says Rezatapopt Posts 46% Response Rate in Phase 2 Platinum-Resistant Ovarian Cancer Trial

Reuters
·
Sep 01

PMV Pharmaceuticals, - Median Time to Response 1.3 Months, Median Duration of Response 10.0 Months

THOMSON REUTERS
·
Sep 01

PMV Pharmaceuticals, - Rezatapopt Shows Favorable Safety Profile with 5% Discontinuation Rate Due to Adverse Events

THOMSON REUTERS
·
Sep 01

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data from Pynnacle Phase 2 Pivotal Trial

THOMSON REUTERS
·
Sep 01

PMV Pharmaceuticals Q2 EPS USD -0.34

Reuters
·
Aug 14

PMV Pharma Q2 EPS $(0.34) Beats $(0.39) Estimate

Benzinga Earnings
·
Aug 14

PMV Pharma Q2 FY26 Net Loss Narrows 14.73% to $18.09 Million

Reuters
·
Aug 14

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights

THOMSON REUTERS
·
Aug 14

PMV Pharmaceuticals Q2 Net Income USD -18.086 Million

THOMSON REUTERS
·
Aug 14

PMV Pharmaceuticals Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 03

PMV Pharmaceuticals Coverage Assumed by Ladenburg Thalmann at Buy

Dow Jones
·
Jul 08

PMV Pharmaceuticals shareholders elect two directors at annual meeting

Reuters
·
Jun 05

PMV Pharmaceuticals (NASDAQ:PMVP) Will Have To Spend Its Cash Wisely

Simply Wall St.
·
May 19

PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer

TIPRANKS
·
May 13

PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)

TIPRANKS
·
May 13

PMV Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12